Loading stock data…
Outset Medical (OM)
$4.33-0.25 (-5.46%)
After Hours$4.33+0.00 (+0.00%)· Last close Jun 29
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Outset Medical, Inc. in the Healthcare sector is trading at $4.33 with a market capitalization of $83M. Wall Street consensus targets $7.67 (3 analysts), implying a +77.1% move over the next 12 months. The stock is currently near its 52-week low of $3.00, remaining 31.6% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +77.1% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $27.86M↓ | $28.87M↓ | $29.43M↓ | $31.42M↑ | $29.75M |
| Gross Profit | $12.10M↓ | $12.23M↑ | $11.59M↓ | $11.87M↑ | $11.07M |
| Operating Income | -$16.92M↑ | -$17.63M↓ | -$15.81M↑ | -$16.86M↓ | -$16.40M |
| Net Income | -$18.98M↑ | -$19.49M↓ | -$17.84M↑ | -$18.54M↑ | -$25.78M |
Peer Comparison
JNJUNHPFE
Fundamentals
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-de...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$82.77M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-67.02%
Volume
Today's trading volume
378,657
Recent News
Outset Medical (OM) Surges 25.6%: Is This an Indication of Further Gains?
Outset Medical (OM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Here’s Why Outset Medical (OM) Rebound Sharply After Last Quarter’s Selloff
Minot Light Capital Partners, an investment management company, released its “Capital Appreciation Fund” Q1 2026 Investor Letter. A copy of the letter can be downloaded here. The fund declined by 2.7% in the first quarter of 2026 due to a sharp macro-driven sector rotation following geopolitical tensions, which triggered inflation fears and rising interest rate […]
Outset Medical (OM) Q4 2025 Earnings Transcript
2025 was a year of progress and transformation at Outset Medical, a year where we overcame adversity to emerge with a stronger foundation and even deeper capabilities to help hospitals, health systems, post-acute and home providers improve patient care outcomes at lower cost and with less complexity. Gross margin exiting the year was well above 40%, which keeps us on a trajectory to our next milestone of 50%.
Outset Medical Q1 Earnings Call Highlights
Outset Medical (NASDAQ:OM) reported first-quarter 2026 revenue of $27.9 million, as management pointed to “consistent execution” in console utilization, new customer additions, gross margin expansion, and cash discipline, while acknowledging that capital order timing weighed on results. Chair and C
Outset Medical, Inc. (OM) Reports Q1 Loss, Lags Revenue Estimates
Outset Medical (OM) delivered earnings and revenue surprises of -5.06% and -3.59%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?